Eric Fearon | |
---|---|
Born | Maine, US |
Spouse | Kathleen R. Cho |
Academic background | |
Education | BA, Biophysics, 1983, MD, 1990, PhD, Biology/Program in Human Genetics, 1990, Johns Hopkins University |
Thesis | A genetic model of colorectal tumorigenesis (1990) |
Academic work | |
Institutions | University of Michigan |
Eric Reese Fearon is an American oncologist. He is the Emanuel N. Maisel Professor of Oncology at the University of Michigan and director of the University of Michigan Rogel Cancer Center.
Fearon was born to parents Margaret and Ross in Maine and grew up alongside his older sister Gretchen. [1] He attended Mt. Blue High School in Farmington,Maine [2] before enrolling at Johns Hopkins University for his Bachelor of Arts degree,medical degree,and PhD. During his graduate studies at Johns Hopkins,Fearon was inducted into the Phi Beta Kappa. [3]
After receiving his medical and doctoral degrees,Fearon conducted his postdoctoral research in the laboratory of Chi Van Dang,where he developed a system for the study of protein-protein interactions in living mammalian cells. [4] Fearon also enrolled at the MD Anderson Cancer Center and was awarded the Wilson S. Stone Memorial Award. [5]
Fearon joined the University of Michigan (U-M) in 1995 as the associate director for Basic Science Research at the University of Michigan Rogel Cancer Center. [6] In 1999,Fearon was elected a Fellow of the American Society for Clinical Investigation (ASCI). [7] He later served as president of the ASCI from 2005 to 2006. [4] He was named deputy director of the Rogel Cancer Center in 2005 and was Director in 2016. [8]
During his tenure at U-M,Fearon's laboratory conducts research with the aim to address how cancer gene defects contribute to the development and progression of colorectal and other cancers. By 2013,he also served as the division chief of Molecular Medicine &Genetics in the Department of Internal Medicine and co-directed the U-M Cancer Center's Cancer Genetics Research Program. [9] Fearon also chaired the National Institutes of Health and National Cancer Institute advisory groups and grant review committees. [6] As a result of his research,Fearon was elected a member of the National Academy of Medicine. [9] A few years later,Fearon was awarded the Distinguished Faculty Lectureship Award in Biomedical Research for being "a giant in the field of carcinogenesis,specifically colorectal cancer." [10]
In 2018,Fearon was named a fellow of the American Association for the Advancement of Science for "distinguished contributions to the cancer field,particularly in defining the role of accumulated mutations in oncogenes and tumor suppressor genes in colon cancer pathogenesis." [11]
Fearon and his wife,Kathleen R. Cho,have two daughters together. [12]
The Johns Hopkins University School of Medicine (JHUSOM) is the medical school of Johns Hopkins University,a private research university in Baltimore,Maryland. Founded in 1893,the School of Medicine shares a campus with the Johns Hopkins Hospital and Johns Hopkins Children's Center,established in 1889. It has consistently ranked among the top medical schools in the United States in terms of the number/amount of research grants/funding awarded by the National Institutes of Health,among other measures.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
Wafik El-Deiry is an American physician and cancer researcher who is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School,Brown University,Director of the Cancer Center at Brown University,and the Director of the Joint Program in Cancer Biology at Brown University and its affiliated hospitals. He was previously Deputy Director of Translational Research at Fox Chase Cancer Center,where he was also co-Leader of the Molecular Therapeutics Program.
Larry Kwak is an American cancer researcher who works at City of Hope in Duarte,California and is the Director of the Toni Stephenson Lymphoma Center at City of Hope. Dr. Kwak formerly worked at the University of Texas MD Anderson Cancer Center. He was included on Time's list of 2010's most influential people.
Daniel Albo is an American surgeon,medical researcher,and pioneer in minimally invasive gastrointestinal surgical oncology. He has published in areas including laparoscopic colorectal surgery and surgical oncology. He is the director of surgical oncology services and the director of health services research at the Georgia Regents University Cancer Center.
Gregg Leonard Semenza is a Pediatrician and Professor of Genetic Medicine at the Johns Hopkins School of Medicine. He serves as the director of the vascular program at the Institute for Cell Engineering. He is a 2016 recipient of the Albert Lasker Award for Basic Medical Research. He is known for his discovery of HIF-1,which allows cancer cells to adapt to oxygen-poor environments. He shared the 2019 Nobel Prize in Physiology or Medicine for "discoveries of how cells sense and adapt to oxygen availability" with William Kaelin Jr. and Peter J. Ratcliffe.
Nita Ahuja is a surgeon and the Chair of the Department of Surgery at Yale School of Medicine and Surgeon-in-Chief of Surgery at Yale New Haven Hospital. She is the first woman ever to serve as Chair of Surgery in Yale in its >200 year history. Before taking this position she was the first woman ever to be the Chief of Surgical Oncology at Johns Hopkins Hospital,Baltimore,USA. Ahuja researches in the field of epigenetics and is a passionate advocate of clinician scientist. She also served as the director of Sarcoma and peritoneal surface malignancy program. She is a surgeon-scientist and her research has been cited more than 11,000 times in scientific literature.
David A. Scheinberg,M.D.,Ph.D. is a physician,scientist,drug developer,and entrepreneur,who is currently Vincent Astor Chair,and Chairman of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK). He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.
Bhramar Mukherjee is an Indian-American biostatistician,data scientist,professor and researcher. She is the John D. Kalbfleisch Collegiate Professor and the Chair of Department of Biostatistics,a professor of epidemiology at the University of Michigan. She serves as the associate director for Quantitative Data Sciences at University of Michigan Rogel Cancer Center. She is the Chair elect for Committee of Presidents of Statistical Societies (COPSS) for a three-year term starting 2019.
The University of Michigan Rogel Cancer Center is a cancer research and treatment institution based in Ann Arbor,Michigan,United States. The Rogel Cancer Center is affiliated with the University of Michigan and Michigan Medicine.
Maria G. Castro is the R. C. Schneider Collegiate Professor of Neurosurgery and a Professor of Cell and Developmental Biology at the University of Michigan Medical School. Her research focuses on cancer immunology and gliomas.
Levi A. Garraway is an American oncologist. His research team was among the first to adapt genomics technologies to enable scalable,high-throughput clinical approaches to cancer gene mutation profiling. As a result,he was inducted into the American Society for Clinical Investigation,American Association for Cancer Research,and National Academy of Medicine.
Maura Lianne Gillison is an American medical oncologist and molecular epidemiologist. She is credited as the first investigator to establish a connection between HPV and oral cancer.
Christopher Ryan Friese is an American nurse scientist. In 2020,he was elected to membership in the National Academy of Medicine and in 2021,was appointed to the National Cancer Advisory Board.
Kathleen R. Cho is an American gynecological surgical pathologist. She is a Professor of Pathology and Internal Medicine at Michigan Medicine.
Andrew Mark Pardoll is Director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy and Abeloff Professor of Oncology,Medicine,Pathology and Molecular Biology and Genetics at Johns Hopkins University,School of Medicine. He is also Director of the Cancer Immunology Program at the Sidney Kimmel Comprehensive Cancer Center.
Theodore Steven Lawrence is an American radiation oncologist. In 2015,Lawrence was appointed the director of the University of Michigan Rogel Cancer Center.
Chi Van Dang is a hematological oncologist and researcher,currently serving as the Scientific Director of Ludwig Institute for Cancer Research. He is known for his research on genetics,the MYC gene and the cellular energy metabolism of cancer.
Timothy Michael Pawlik is an American oncologist. He is the Chair of Surgery at Ohio State University Wexner Medical Center and the Urban Meyer III and Shelley Meyer Chair for Cancer Research.
W. Kimryn Rathmell is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC),and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville,Tennessee.